RECORD // Company

Scilex Holding Co

Formerly: Scilex Holding Company/DE; Vickers Vantage Corp. I

Built 2026-11-22T05:16:02Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (2 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

Gleif lei (1)
SEC EDGAR (1)

4 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-06-30, filed 2026-08-14 · accession 0001193125-26-352464

ItemValuePeriodFormFiledAccessionReport
Revenue$7,642,0003 months ended 2026-06-3010-Q2026-08-140001193125-26-3524642026-11-22 05:16 UTCReport an error
Net income (loss)$-114,986,0003 months ended 2026-06-3010-Q2026-08-140001193125-26-3524642026-11-22 05:16 UTCReport an error
Interest expense$6,104,0003 months ended 2026-06-3010-Q2026-08-140001193125-26-3524642026-11-22 05:16 UTCReport an error
Cash and cash equivalents$566,000at 2026-06-3010-Q2026-08-140001193125-26-3524642026-11-22 05:16 UTCReport an error

Negative as reported in the filing.

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0001820190
Ticker
SCLX
CUSIP
86633R609
Record ID
sx:sec:0001820190

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

33 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-20SEC EDGAR company profile2026-11-22 05:16 UTCReport an error
SIC industry2836 Biological Products, (No Diagnostic Substances)2026-11-20SEC EDGAR company profile2026-11-22 05:16 UTCReport an error
State of incorporationDE2026-11-20SEC EDGAR company profile2026-11-22 05:16 UTCReport an error
Fiscal year end (MMDD)12312026-11-20SEC EDGAR company profile2026-11-22 05:16 UTCReport an error
Business address960 SAN ANTONIO ROAD, PALO ALTO, CA, 943032026-11-20SEC EDGAR company profile2026-11-22 05:16 UTCReport an error
ExchangesNasdaq, Nasdaq2026-11-20SEC EDGAR company profile2026-11-22 05:16 UTCReport an error
Revenue (fiscal year ended 2025-12-31)$30,253,0002025-12-3110-K, XBRL Revenues2026-11-22 05:16 UTCReport an error
Net income (loss) (fiscal year ended 2025-12-31)$-374,053,0002025-12-3110-K, XBRL NetIncomeLoss2026-11-22 05:16 UTCReport an error
Total assets (at 2025-12-31)$364,981,0002025-12-3110-K, XBRL Assets2026-11-22 05:16 UTCReport an error
Stockholders' equity (at 2025-12-31)$-207,781,0002025-12-3110-K, XBRL StockholdersEquity2026-11-22 05:16 UTCReport an error
Cash and cash equivalents (at 2025-12-31)$4,955,0002025-12-3110-K, XBRL CashAndCashEquivalentsAtCarryingValue2026-11-22 05:16 UTCReport an error
Operating cash flow (fiscal year ended 2025-12-31)$3,816,0002025-12-3110-K, XBRL NetCashProvidedByUsedInOperatingActivities2026-11-22 05:16 UTCReport an error
Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31)$133,0002025-12-3110-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment2026-11-22 05:16 UTCReport an error
Operating lease liabilities (at 2025-12-31)$14,884,0002025-12-3110-K, XBRL OperatingLeaseLiability2026-11-22 05:16 UTCReport an error
Form D total offering amount (D filed 2025-10-14)$2,688,5402025-10-14D2026-11-22 05:16 UTCReport an error
Form D total amount sold (D filed 2025-10-14)$2,688,5402025-10-14D2026-11-22 05:16 UTCReport an error
Form D industry groupBiotechnology2025-10-14D2026-11-22 05:16 UTCReport an error
Form D revenue range$25,000,001 - $100,000,0002025-10-14D2026-11-22 05:16 UTCReport an error
Form D date of first sale2025-09-302025-10-14D2026-11-22 05:16 UTCReport an error
8-K Item 3.01, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (filed 2026-11-20)On November 17, 2026, Scilex Holding Company (the “Company”) was notified by the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) that, for the 30 consecutive business days from October 6, 2026 through November 16, 2026, the market value of the Company’s listed securities (“MVLS”) was below the minimum of $35 million required for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(2) (the “MVLS Requirement,” and such notice, the “Notice”). The Notice also indicated that the Company does not meet the alternative continued listing standards under Nasdaq Listing Rules 5550(b)(1) and 5550(b)(3), relating to minimum stockholders’ equity and…2026-11-20SEC EDGAR 8-K 0001193125-26-470221 (text as filed, excerpt)2026-11-22 05:16 UTCReport an error
8-K Item 4.01, Changes in Registrant’s Certifying Accountant (filed 2026-11-17)Dismissal of Independent Registered Public Accounting Firm On November 11, 2026, the audit committee (the “Committee”) of the board of directors of Scilex Holding Company (the “Company”) approved the dismissal of BPM LLP (“BPM”) as the Company’s independent registered public accounting firm. The Company notified BPM of the dismissal on November 16, 2026. The reports of BPM on the consolidated financial statements of the Company for the fiscal years ended December 31, 2025 and December 31, 2024 did not contain an adverse opinion or a disclaimer of opinion, and were not qualified or modified as to uncertainty, audit scope or accounting principles, except for an explanatory paragraph in each…2026-11-17SEC EDGAR 8-K 0001193125-26-465507 (text as filed, excerpt)2026-11-22 05:16 UTCReport an error
8-K Item 1.01, Entry into a Material Definitive Agreement (filed 2026-09-29)As previously disclosed, on August 8, 2026, Scilex Holding Company (the “Company”) entered into a Promissory Note (Revolving Line of Credit) (the “Note”) with Vivasor, Inc. (“Vivasor”), as borrower, pursuant to which the Company established in favor of Vivasor an uncommitted revolving line of credit in a maximum aggregate principal amount of up to $20,000,000 (the “Maximum Credit Amount”). On September 25, 2026, the Company and Vivasor entered into an amendment to the Note (the “Amendment”), pursuant to which the Maximum Credit Amount was increased from $20,000,000 to $30,000,000. No other changes were made to the Note. Dr. Henry Ji, Ph.D., the Company’s current Chief Executive Officer…2026-09-29SEC EDGAR 8-K 0001193125-26-407333 (text as filed, excerpt)2026-11-22 05:16 UTCReport an error
8-K Item 1.01, Entry into a Material Definitive Agreement (filed 2026-08-12)On August 8, 2026 (the “Effective Date”), Scilex Holding Company (the “Company”) entered into a Promissory Note (Revolving Line of Credit) (the “Note”) with Vivasor, Inc. (“Vivasor”), as borrower, pursuant to which the Company established in favor of Vivasor an uncommitted revolving line of credit in a maximum aggregate principal amount of up to $20,000,000 (the “Maximum Credit Amount”). The Note has a stated maturity of 120 months from the Effective Date (the “Maturity Date”). The Note evidences a revolving credit facility under which Vivasor may, from time to time prior to the Maturity Date, request advances (“Drawdowns”) in multiple borrowings, provided that the aggregate outstanding…2026-08-12SEC EDGAR 8-K 0001193125-26-347186 (text as filed, excerpt)2026-11-22 05:16 UTCReport an error
Largest institutional holder #1 (13F as filed): VANGUARD CAPITAL MANAGEMENT LLC$9,339,1292026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 05:16 UTCReport an error
Largest institutional holder #2 (13F as filed): BlackRock, Inc.$4,030,0642026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 05:16 UTCReport an error
Largest institutional holder #3 (13F as filed): VANGUARD FIDUCIARY TRUST CO$1,310,2852026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 05:16 UTCReport an error
Largest institutional holder #4 (13F as filed): STATE STREET CORP$1,088,2162026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 05:16 UTCReport an error
Largest institutional holder #5 (13F as filed): UBS Group AG$826,7302026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 05:16 UTCReport an error
Largest institutional holder #6 (13F as filed): Themes Management Co LLC$627,3672026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 05:16 UTCReport an error
Largest institutional holder #7 (13F as filed): NORTHERN TRUST CORP$477,3452026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 05:16 UTCReport an error
Largest institutional holder #8 (13F as filed): Balyasny Asset Management L.P.$230,8752026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 05:16 UTCReport an error
Largest institutional holder #9 (13F as filed): SUSQUEHANNA INTERNATIONAL GROUP, LLP$186,8882026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 05:16 UTCReport an error
Largest institutional holder #10 (13F as filed): FRANKLIN RESOURCES INC$181,2222026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 05:16 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.